Outcomes to first-line pembrolizumab in patients with non-small cell lung cancer and a PD-L1 tumor proportion score ≥90% Meeting Abstract
| Authors: | Jimenez Aguilar, E.; Ricciuti, B.; Gainor, J. F.; Nishino, M.; Adeni, A. E.; Subegdjo, S.; Khosrowjerdi, S.; Peterson, R.; Digumarthy, S.; Liu, C.; Sauter, J. L.; Rizvi, H.; Arbour, K. C.; Carter, B. W.; Heymach, J.; Altan, M.; Hellmann, M. D.; Awad, M. M. |
| Abstract Title: | Outcomes to first-line pembrolizumab in patients with non-small cell lung cancer and a PD-L1 tumor proportion score ≥90% |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 503s |
| Language: | English |
| ACCESSION: | WOS:000487345806551 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.9111 |
| Notes: | Meeting Abstract: 9111 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
